Vanessa (Gray) Hasle
Vanessa (Gray) Hasle
Scientist I at Bristol Myers Squibb
Verified email at celgene.com
Title
Cited by
Cited by
Year
Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis
SC Palmer, D Mavridis, A Nicolucci, DW Johnson, M Tonelli, JC Craig, ...
Jama 316 (3), 313-324, 2016
2912016
Multiplex assessment of protein variant abundance by massively parallel sequencing
KA Matreyek, LM Starita, JJ Stephany, B Martin, MA Chiasson, VE Gray, ...
Nature genetics 50 (6), 874-882, 2018
932018
Evolutionary diagnosis method for variants in personal exomes
S Kumar, M Sanderford, VE Gray, J Ye, L Liu
Nature Methods 9 (9), 855 - 856, 2012
582012
Performance of computational tools in evaluating the functional impact of laboratory-induced amino acid mutations
VE Gray, KR Kukurba, S Kumar
Bioinformatics 28 (16), 2093-2096, 2012
532012
Quantitative Missense Variant Effect Prediction Using Large-Scale Mutagenesis Data
DMF Vanessa E. Gray, Ronald J. Hause, Jens Luebeck, Jay Shendure
Cell Systems, 2017
51*2017
Analysis of large-scale mutagenesis data to assess the impact of single amino acid substitutions
VE Gray, RJ Hause, DM Fowler
Genetics 207 (1), 53-61, 2017
352017
Rampant Purifying Selection Conserves Positions with Posttranslational Modifications in Human Proteins
VE Gray, S Kumar
Molecular Biology and Evolution 28 (5), 1565, 2011
242011
A molecular evolutionary reference for the human variome
L Liu, K Tamura, M Sanderford, VE Gray, S Kumar
Molecular biology and evolution 33 (1), 245-254, 2015
92015
Signatures of natural selection on mutations of residues with multiple posttranslational modifications
VE Gray, L Liu, R Nirankari, PV Hornbeck, S Kumar
Molecular biology and evolution 31 (7), 1641-1645, 2014
82014
Efficacy and safety of azacitidine (AZA) in combination with the Anti-PD-L1 durvalumab (durva) for the front-line treatment of older patients (pts) with Acute Myeloid Leukemia …
AM Zeidan, J Cavenagh, MT Voso, D Taussig, M Tormo, I Boss, ...
Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019
42019
Multiplexed immunofluorescence (IF) analysis and gene expression profiling of biopsies from patients with relapsed/refractory (R/R) diffuse large B cell lymphoma (DLBCL …
DJ Reiss, T Do, D Kuo, VE Gray, NE Olson, CW Lee, MH Young, ...
Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019
22019
Elucidating the Molecular Determinants of Aβ Aggregation with Deep Mutational Scanning
DMF Vanessa E. Gray, Katherine Sitko, Floriane Z. Ngako Kameni, Miriam ...
G3: GENES, GENOMES, GENETICS 9 (11), 3683-3689, 2019
22019
RESEARCH OUTPUTS REPORTING INDIGENOUS HEALTH OUTCOMES IN THE AUSTRALIA AND NEW ZEALAND DIALYSIS AND TRANSPLANT REGISTRY (ANZDATA): SYSTEMATIC REVIEW
SC Palmer, SG Pitama, V Gray, T Kara, JT Hughes
NEPHROLOGY 22, 18-19, 2017
22017
The Evolutionary History of Amino Acid Variations Mediating Increased Resistance of S. aureus Identifies Reversion Mutations in Metabolic Regulators
SK Mia D. Champion, Vanessa Gray, Carl Eberhard
PLOS ONE 8 (2), 2013
22013
Using large-scale mutagenesis to guide single amino acid scanning experiments
VE Gray, RJ Hause, DM Fowler
BioRxiv, 140707, 2017
12017
Preprint highlights, selected by the biological community
JA Smolka, LA Sanz, SR Hartono, F Chédin
Cell 179 (3), 604-618, 2019
2019
SP626 A SYSTEMATIC REVIEW OF NON-PHARMACOLOGICAL INTERVENTIONS TO PROMOTE ADHERENCE TO DIETARY SALT AND FLUID INTAKE RESTRICTIONS IN END-STAGE KIDNEY DISEASE
M Wong, J Craig, A Levin, G Strippoli, V Gray, S Palmer
Nephrology Dialysis Transplantation 32 (3), iii347-iii347, 2017
2017
Learning from Large-scale Mutagenesis Data
VE Gray
2017
Preprint highlights, selected by the biological community
BS Hercyk, JT Rich-Robinson, AS Mitoubsi, MA Harrell, ME Das
Preprint highlights, selected by the biological community
JF McKenna, D Rolfe, SED Webb, AF Tolmie, SW Botchway, ...
The system can't perform the operation now. Try again later.
Articles 1–20